KeyBanc Initiates Amsurg At Buy

Analysts at KeyBanc initiated coverage on shares of Amsurg

with a Buy rating. The target price for Amsurg is set to $65. Amsurg shares have jumped 35.93% over the past 52 weeks, while the S&P 500 index has gained 18.65% in the same period. Amsurg's shares rose 0.79% to close at $52.44 yesterday.